nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP1A2—Pentoxifylline—systemic scleroderma	0.132	0.222	CbGbCtD
Tranylcypromine—CYP1A2—Leflunomide—systemic scleroderma	0.126	0.212	CbGbCtD
Tranylcypromine—CYP2C9—Leflunomide—systemic scleroderma	0.113	0.191	CbGbCtD
Tranylcypromine—CYP2D6—Captopril—systemic scleroderma	0.0812	0.137	CbGbCtD
Tranylcypromine—CYP2C19—Prednisone—systemic scleroderma	0.0672	0.114	CbGbCtD
Tranylcypromine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0407	0.0687	CbGbCtD
Tranylcypromine—CYP3A4—Prednisone—systemic scleroderma	0.0325	0.0549	CbGbCtD
Tranylcypromine—CYP2C9—cardial valve—systemic scleroderma	0.0135	0.518	CbGeAlD
Tranylcypromine—MAOB—connective tissue—systemic scleroderma	0.00119	0.0459	CbGeAlD
Tranylcypromine—MAOA—connective tissue—systemic scleroderma	0.00102	0.0392	CbGeAlD
Tranylcypromine—CYP2A6—lung—systemic scleroderma	0.000975	0.0376	CbGeAlD
Tranylcypromine—Dizziness—Pentoxifylline—systemic scleroderma	0.00096	0.00251	CcSEcCtD
Tranylcypromine—Hypertension—Leflunomide—systemic scleroderma	0.000959	0.00251	CcSEcCtD
Tranylcypromine—Decreased appetite—Captopril—systemic scleroderma	0.000956	0.0025	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000956	0.0025	CcSEcCtD
Tranylcypromine—Syncope—Mycophenolic acid—systemic scleroderma	0.00095	0.00249	CcSEcCtD
Tranylcypromine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000949	0.00248	CcSEcCtD
Tranylcypromine—Anxiety—Leflunomide—systemic scleroderma	0.000943	0.00247	CcSEcCtD
Tranylcypromine—Constipation—Captopril—systemic scleroderma	0.000941	0.00246	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00094	0.00246	CcSEcCtD
Tranylcypromine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000937	0.00245	CcSEcCtD
Tranylcypromine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000932	0.00244	CcSEcCtD
Tranylcypromine—Dry mouth—Leflunomide—systemic scleroderma	0.000925	0.00242	CcSEcCtD
Tranylcypromine—Vomiting—Pentoxifylline—systemic scleroderma	0.000923	0.00242	CcSEcCtD
Tranylcypromine—Muscle spasms—Lisinopril—systemic scleroderma	0.000918	0.0024	CcSEcCtD
Tranylcypromine—Rash—Pentoxifylline—systemic scleroderma	0.000915	0.0024	CcSEcCtD
Tranylcypromine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000915	0.0024	CcSEcCtD
Tranylcypromine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000914	0.00239	CcSEcCtD
Tranylcypromine—Headache—Pentoxifylline—systemic scleroderma	0.000909	0.00238	CcSEcCtD
Tranylcypromine—Feeling abnormal—Captopril—systemic scleroderma	0.000907	0.00237	CcSEcCtD
Tranylcypromine—Vision blurred—Lisinopril—systemic scleroderma	0.0009	0.00236	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Captopril—systemic scleroderma	0.0009	0.00236	CcSEcCtD
Tranylcypromine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000899	0.00235	CcSEcCtD
Tranylcypromine—Asthenia—Mometasone—systemic scleroderma	0.000899	0.00235	CcSEcCtD
Tranylcypromine—Hypotension—Azathioprine—systemic scleroderma	0.000897	0.00235	CcSEcCtD
Tranylcypromine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000896	0.00235	CcSEcCtD
Tranylcypromine—Tremor—Lisinopril—systemic scleroderma	0.000894	0.00234	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000888	0.00232	CcSEcCtD
Tranylcypromine—Tachycardia—Leflunomide—systemic scleroderma	0.000885	0.00232	CcSEcCtD
Tranylcypromine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000882	0.00231	CcSEcCtD
Tranylcypromine—Anaemia—Lisinopril—systemic scleroderma	0.000882	0.00231	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000877	0.0023	CcSEcCtD
Tranylcypromine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000872	0.00228	CcSEcCtD
Tranylcypromine—Body temperature increased—Captopril—systemic scleroderma	0.00087	0.00228	CcSEcCtD
Tranylcypromine—Abdominal pain—Captopril—systemic scleroderma	0.00087	0.00228	CcSEcCtD
Tranylcypromine—Oedema—Mycophenolic acid—systemic scleroderma	0.000865	0.00226	CcSEcCtD
Tranylcypromine—Anorexia—Leflunomide—systemic scleroderma	0.000864	0.00226	CcSEcCtD
Tranylcypromine—Nausea—Pentoxifylline—systemic scleroderma	0.000862	0.00226	CcSEcCtD
Tranylcypromine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000862	0.00226	CcSEcCtD
Tranylcypromine—MAOB—digestive system—systemic scleroderma	0.000862	0.0332	CbGeAlD
Tranylcypromine—Diarrhoea—Mometasone—systemic scleroderma	0.000857	0.00224	CcSEcCtD
Tranylcypromine—Syncope—Lisinopril—systemic scleroderma	0.000856	0.00224	CcSEcCtD
Tranylcypromine—Leukopenia—Lisinopril—systemic scleroderma	0.000855	0.00224	CcSEcCtD
Tranylcypromine—Shock—Mycophenolic acid—systemic scleroderma	0.000851	0.00223	CcSEcCtD
Tranylcypromine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000849	0.00222	CcSEcCtD
Tranylcypromine—Hypotension—Leflunomide—systemic scleroderma	0.000847	0.00222	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000847	0.00222	CcSEcCtD
Tranylcypromine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000844	0.00221	CcSEcCtD
Tranylcypromine—Palpitations—Lisinopril—systemic scleroderma	0.000844	0.00221	CcSEcCtD
Tranylcypromine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000839	0.0022	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000836	0.00219	CcSEcCtD
Tranylcypromine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000825	0.00216	CcSEcCtD
Tranylcypromine—MAOB—tendon—systemic scleroderma	0.00082	0.0316	CbGeAlD
Tranylcypromine—Insomnia—Leflunomide—systemic scleroderma	0.00082	0.00215	CcSEcCtD
Tranylcypromine—Paraesthesia—Leflunomide—systemic scleroderma	0.000814	0.00213	CcSEcCtD
Tranylcypromine—Anxiety—Lisinopril—systemic scleroderma	0.00081	0.00212	CcSEcCtD
Tranylcypromine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000808	0.00212	CcSEcCtD
Tranylcypromine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000804	0.00211	CcSEcCtD
Tranylcypromine—Vomiting—Mometasone—systemic scleroderma	0.000796	0.00209	CcSEcCtD
Tranylcypromine—Dry mouth—Lisinopril—systemic scleroderma	0.000795	0.00208	CcSEcCtD
Tranylcypromine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000791	0.00207	CcSEcCtD
Tranylcypromine—Rash—Mometasone—systemic scleroderma	0.00079	0.00207	CcSEcCtD
Tranylcypromine—Asthenia—Captopril—systemic scleroderma	0.000789	0.00207	CcSEcCtD
Tranylcypromine—Dermatitis—Mometasone—systemic scleroderma	0.000789	0.00207	CcSEcCtD
Tranylcypromine—Decreased appetite—Leflunomide—systemic scleroderma	0.000788	0.00206	CcSEcCtD
Tranylcypromine—Confusional state—Lisinopril—systemic scleroderma	0.000786	0.00206	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000785	0.00206	CcSEcCtD
Tranylcypromine—Headache—Mometasone—systemic scleroderma	0.000785	0.00205	CcSEcCtD
Tranylcypromine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000784	0.00205	CcSEcCtD
Tranylcypromine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000782	0.00205	CcSEcCtD
Tranylcypromine—Oedema—Lisinopril—systemic scleroderma	0.000779	0.00204	CcSEcCtD
Tranylcypromine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000777	0.00203	CcSEcCtD
Tranylcypromine—Constipation—Leflunomide—systemic scleroderma	0.000775	0.00203	CcSEcCtD
Tranylcypromine—Pain—Leflunomide—systemic scleroderma	0.000775	0.00203	CcSEcCtD
Tranylcypromine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000773	0.00202	CcSEcCtD
Tranylcypromine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000769	0.00201	CcSEcCtD
Tranylcypromine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000769	0.00201	CcSEcCtD
Tranylcypromine—Shock—Lisinopril—systemic scleroderma	0.000767	0.00201	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000763	0.002	CcSEcCtD
Tranylcypromine—Tachycardia—Lisinopril—systemic scleroderma	0.00076	0.00199	CcSEcCtD
Tranylcypromine—Abdominal pain—Azathioprine—systemic scleroderma	0.000759	0.00199	CcSEcCtD
Tranylcypromine—Body temperature increased—Azathioprine—systemic scleroderma	0.000759	0.00199	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000753	0.00197	CcSEcCtD
Tranylcypromine—Diarrhoea—Captopril—systemic scleroderma	0.000753	0.00197	CcSEcCtD
Tranylcypromine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000752	0.00197	CcSEcCtD
Tranylcypromine—CYP2C19—digestive system—systemic scleroderma	0.000751	0.0289	CbGeAlD
Tranylcypromine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00196	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000749	0.00196	CcSEcCtD
Tranylcypromine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000749	0.00196	CcSEcCtD
Tranylcypromine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000747	0.00196	CcSEcCtD
Tranylcypromine—Nausea—Mometasone—systemic scleroderma	0.000744	0.00195	CcSEcCtD
Tranylcypromine—Anorexia—Lisinopril—systemic scleroderma	0.000743	0.00194	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000741	0.00194	CcSEcCtD
Tranylcypromine—Ataxia—Methotrexate—systemic scleroderma	0.00074	0.00194	CcSEcCtD
Tranylcypromine—Constipation—Mycophenolic acid—systemic scleroderma	0.00074	0.00194	CcSEcCtD
Tranylcypromine—Pain—Mycophenolic acid—systemic scleroderma	0.00074	0.00194	CcSEcCtD
Tranylcypromine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000739	0.00194	CcSEcCtD
Tranylcypromine—MAOA—digestive system—systemic scleroderma	0.000735	0.0283	CbGeAlD
Tranylcypromine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000735	0.00192	CcSEcCtD
Tranylcypromine—Hypotension—Lisinopril—systemic scleroderma	0.000728	0.00191	CcSEcCtD
Tranylcypromine—Dizziness—Captopril—systemic scleroderma	0.000728	0.0019	CcSEcCtD
Tranylcypromine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00189	CcSEcCtD
Tranylcypromine—Urticaria—Leflunomide—systemic scleroderma	0.00072	0.00189	CcSEcCtD
Tranylcypromine—MAOB—lung—systemic scleroderma	0.00072	0.0277	CbGeAlD
Tranylcypromine—Abdominal pain—Leflunomide—systemic scleroderma	0.000717	0.00188	CcSEcCtD
Tranylcypromine—Body temperature increased—Leflunomide—systemic scleroderma	0.000717	0.00188	CcSEcCtD
Tranylcypromine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000713	0.00187	CcSEcCtD
Tranylcypromine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00186	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000707	0.00185	CcSEcCtD
Tranylcypromine—Insomnia—Lisinopril—systemic scleroderma	0.000705	0.00184	CcSEcCtD
Tranylcypromine—MAOA—tendon—systemic scleroderma	0.0007	0.0269	CbGeAlD
Tranylcypromine—Paraesthesia—Lisinopril—systemic scleroderma	0.0007	0.00183	CcSEcCtD
Tranylcypromine—Vomiting—Captopril—systemic scleroderma	0.0007	0.00183	CcSEcCtD
Tranylcypromine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000696	0.00182	CcSEcCtD
Tranylcypromine—Rash—Captopril—systemic scleroderma	0.000694	0.00182	CcSEcCtD
Tranylcypromine—Dermatitis—Captopril—systemic scleroderma	0.000693	0.00181	CcSEcCtD
Tranylcypromine—Somnolence—Lisinopril—systemic scleroderma	0.000693	0.00181	CcSEcCtD
Tranylcypromine—Headache—Captopril—systemic scleroderma	0.000689	0.0018	CcSEcCtD
Tranylcypromine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000688	0.0018	CcSEcCtD
Tranylcypromine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000684	0.00179	CcSEcCtD
Tranylcypromine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000684	0.00179	CcSEcCtD
Tranylcypromine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000683	0.00179	CcSEcCtD
Tranylcypromine—Decreased appetite—Lisinopril—systemic scleroderma	0.000677	0.00177	CcSEcCtD
Tranylcypromine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000672	0.00176	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000668	0.00175	CcSEcCtD
Tranylcypromine—Pain—Lisinopril—systemic scleroderma	0.000666	0.00174	CcSEcCtD
Tranylcypromine—Constipation—Lisinopril—systemic scleroderma	0.000666	0.00174	CcSEcCtD
Tranylcypromine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000666	0.00174	CcSEcCtD
Tranylcypromine—Bradycardia—Prednisone—systemic scleroderma	0.000663	0.00174	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00066	0.00173	CcSEcCtD
Tranylcypromine—Diarrhoea—Azathioprine—systemic scleroderma	0.000657	0.00172	CcSEcCtD
Tranylcypromine—Haemoglobin—Prednisone—systemic scleroderma	0.000655	0.00171	CcSEcCtD
Tranylcypromine—Nausea—Captopril—systemic scleroderma	0.000653	0.00171	CcSEcCtD
Tranylcypromine—Haemorrhage—Prednisone—systemic scleroderma	0.000651	0.00171	CcSEcCtD
Tranylcypromine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000651	0.0017	CcSEcCtD
Tranylcypromine—Asthenia—Leflunomide—systemic scleroderma	0.000651	0.0017	CcSEcCtD
Tranylcypromine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000642	0.00168	CcSEcCtD
Tranylcypromine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000638	0.00167	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000637	0.00167	CcSEcCtD
Tranylcypromine—Dizziness—Azathioprine—systemic scleroderma	0.000635	0.00166	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000626	0.00164	CcSEcCtD
Tranylcypromine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000621	0.00162	CcSEcCtD
Tranylcypromine—Diarrhoea—Leflunomide—systemic scleroderma	0.00062	0.00162	CcSEcCtD
Tranylcypromine—Urticaria—Lisinopril—systemic scleroderma	0.000619	0.00162	CcSEcCtD
Tranylcypromine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000617	0.00162	CcSEcCtD
Tranylcypromine—Body temperature increased—Lisinopril—systemic scleroderma	0.000616	0.00161	CcSEcCtD
Tranylcypromine—Abdominal pain—Lisinopril—systemic scleroderma	0.000616	0.00161	CcSEcCtD
Tranylcypromine—MAOA—lung—systemic scleroderma	0.000614	0.0236	CbGeAlD
Tranylcypromine—CYP1A2—digestive system—systemic scleroderma	0.000614	0.0236	CbGeAlD
Tranylcypromine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000613	0.0016	CcSEcCtD
Tranylcypromine—Vomiting—Azathioprine—systemic scleroderma	0.00061	0.0016	CcSEcCtD
Tranylcypromine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00159	CcSEcCtD
Tranylcypromine—Drowsiness—Methotrexate—systemic scleroderma	0.000606	0.00159	CcSEcCtD
Tranylcypromine—Rash—Azathioprine—systemic scleroderma	0.000605	0.00159	CcSEcCtD
Tranylcypromine—Dermatitis—Azathioprine—systemic scleroderma	0.000605	0.00158	CcSEcCtD
Tranylcypromine—Flushing—Prednisone—systemic scleroderma	0.000604	0.00158	CcSEcCtD
Tranylcypromine—Headache—Azathioprine—systemic scleroderma	0.000602	0.00157	CcSEcCtD
Tranylcypromine—Dizziness—Leflunomide—systemic scleroderma	0.0006	0.00157	CcSEcCtD
Tranylcypromine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00155	CcSEcCtD
Tranylcypromine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000592	0.00155	CcSEcCtD
Tranylcypromine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000584	0.00153	CcSEcCtD
Tranylcypromine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000584	0.00153	CcSEcCtD
Tranylcypromine—CYP2C9—digestive system—systemic scleroderma	0.000582	0.0224	CbGeAlD
Tranylcypromine—Sweating—Methotrexate—systemic scleroderma	0.000581	0.00152	CcSEcCtD
Tranylcypromine—Vomiting—Leflunomide—systemic scleroderma	0.000577	0.00151	CcSEcCtD
Tranylcypromine—Alopecia—Prednisone—systemic scleroderma	0.000576	0.00151	CcSEcCtD
Tranylcypromine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000572	0.0015	CcSEcCtD
Tranylcypromine—Rash—Leflunomide—systemic scleroderma	0.000572	0.0015	CcSEcCtD
Tranylcypromine—Dermatitis—Leflunomide—systemic scleroderma	0.000571	0.0015	CcSEcCtD
Tranylcypromine—Nausea—Azathioprine—systemic scleroderma	0.00057	0.00149	CcSEcCtD
Tranylcypromine—Headache—Leflunomide—systemic scleroderma	0.000568	0.00149	CcSEcCtD
Tranylcypromine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000566	0.00148	CcSEcCtD
Tranylcypromine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000563	0.00147	CcSEcCtD
Tranylcypromine—Asthenia—Lisinopril—systemic scleroderma	0.000559	0.00146	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000558	0.00146	CcSEcCtD
Tranylcypromine—CYP2E1—digestive system—systemic scleroderma	0.000552	0.0213	CbGeAlD
Tranylcypromine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00055	0.00144	CcSEcCtD
Tranylcypromine—Haemoglobin—Methotrexate—systemic scleroderma	0.000547	0.00143	CcSEcCtD
Tranylcypromine—Rash—Mycophenolic acid—systemic scleroderma	0.000545	0.00143	CcSEcCtD
Tranylcypromine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000545	0.00143	CcSEcCtD
Tranylcypromine—Haemorrhage—Methotrexate—systemic scleroderma	0.000544	0.00143	CcSEcCtD
Tranylcypromine—Hepatitis—Methotrexate—systemic scleroderma	0.000544	0.00143	CcSEcCtD
Tranylcypromine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000542	0.00142	CcSEcCtD
Tranylcypromine—Headache—Mycophenolic acid—systemic scleroderma	0.000542	0.00142	CcSEcCtD
Tranylcypromine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00141	CcSEcCtD
Tranylcypromine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00141	CcSEcCtD
Tranylcypromine—Nausea—Leflunomide—systemic scleroderma	0.000539	0.00141	CcSEcCtD
Tranylcypromine—Vision blurred—Prednisone—systemic scleroderma	0.000534	0.0014	CcSEcCtD
Tranylcypromine—Diarrhoea—Lisinopril—systemic scleroderma	0.000533	0.0014	CcSEcCtD
Tranylcypromine—CYP2E1—tendon—systemic scleroderma	0.000525	0.0202	CbGeAlD
Tranylcypromine—Anaemia—Prednisone—systemic scleroderma	0.000524	0.00137	CcSEcCtD
Tranylcypromine—Agitation—Prednisone—systemic scleroderma	0.000521	0.00136	CcSEcCtD
Tranylcypromine—Dizziness—Lisinopril—systemic scleroderma	0.000515	0.00135	CcSEcCtD
Tranylcypromine—Nausea—Mycophenolic acid—systemic scleroderma	0.000514	0.00135	CcSEcCtD
Tranylcypromine—CYP1A2—lung—systemic scleroderma	0.000512	0.0197	CbGeAlD
Tranylcypromine—Syncope—Prednisone—systemic scleroderma	0.000508	0.00133	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—systemic scleroderma	0.000508	0.00133	CcSEcCtD
Tranylcypromine—Loss of consciousness—Prednisone—systemic scleroderma	0.000498	0.0013	CcSEcCtD
Tranylcypromine—Vomiting—Lisinopril—systemic scleroderma	0.000495	0.0013	CcSEcCtD
Tranylcypromine—Rash—Lisinopril—systemic scleroderma	0.000491	0.00129	CcSEcCtD
Tranylcypromine—Dermatitis—Lisinopril—systemic scleroderma	0.000491	0.00129	CcSEcCtD
Tranylcypromine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00049	0.00128	CcSEcCtD
Tranylcypromine—Hypertension—Prednisone—systemic scleroderma	0.00049	0.00128	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—systemic scleroderma	0.000488	0.00128	CcSEcCtD
Tranylcypromine—Headache—Lisinopril—systemic scleroderma	0.000488	0.00128	CcSEcCtD
Tranylcypromine—Anxiety—Prednisone—systemic scleroderma	0.000481	0.00126	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—systemic scleroderma	0.000481	0.00126	CcSEcCtD
Tranylcypromine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000467	0.00122	CcSEcCtD
Tranylcypromine—Nausea—Lisinopril—systemic scleroderma	0.000463	0.00121	CcSEcCtD
Tranylcypromine—Oedema—Prednisone—systemic scleroderma	0.000463	0.00121	CcSEcCtD
Tranylcypromine—CYP2E1—lung—systemic scleroderma	0.000461	0.0177	CbGeAlD
Tranylcypromine—Shock—Prednisone—systemic scleroderma	0.000455	0.00119	CcSEcCtD
Tranylcypromine—Tachycardia—Prednisone—systemic scleroderma	0.000452	0.00118	CcSEcCtD
Tranylcypromine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000451	0.00118	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000447	0.00117	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—systemic scleroderma	0.000447	0.00117	CcSEcCtD
Tranylcypromine—CYP3A4—digestive system—systemic scleroderma	0.000444	0.0171	CbGeAlD
Tranylcypromine—Anorexia—Prednisone—systemic scleroderma	0.000441	0.00115	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—systemic scleroderma	0.000438	0.00115	CcSEcCtD
Tranylcypromine—CYP2D6—digestive system—systemic scleroderma	0.000437	0.0168	CbGeAlD
Tranylcypromine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00114	CcSEcCtD
Tranylcypromine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00113	CcSEcCtD
Tranylcypromine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00113	CcSEcCtD
Tranylcypromine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00112	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—systemic scleroderma	0.000424	0.00111	CcSEcCtD
Tranylcypromine—Insomnia—Prednisone—systemic scleroderma	0.000419	0.0011	CcSEcCtD
Tranylcypromine—Paraesthesia—Prednisone—systemic scleroderma	0.000416	0.00109	CcSEcCtD
Tranylcypromine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000405	0.00106	CcSEcCtD
Tranylcypromine—Decreased appetite—Prednisone—systemic scleroderma	0.000402	0.00105	CcSEcCtD
Tranylcypromine—Constipation—Prednisone—systemic scleroderma	0.000396	0.00104	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—systemic scleroderma	0.00039	0.00102	CcSEcCtD
Tranylcypromine—Feeling abnormal—Prednisone—systemic scleroderma	0.000381	0.000998	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000379	0.000991	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000378	0.000991	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000374	0.000979	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—systemic scleroderma	0.000369	0.000965	CcSEcCtD
Tranylcypromine—Urticaria—Prednisone—systemic scleroderma	0.000368	0.000962	CcSEcCtD
Tranylcypromine—Body temperature increased—Prednisone—systemic scleroderma	0.000366	0.000958	CcSEcCtD
Tranylcypromine—Abdominal pain—Prednisone—systemic scleroderma	0.000366	0.000958	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—systemic scleroderma	0.000361	0.000946	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—systemic scleroderma	0.00035	0.000916	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—systemic scleroderma	0.000347	0.000909	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—systemic scleroderma	0.000344	0.0009	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—systemic scleroderma	0.000336	0.00088	CcSEcCtD
Tranylcypromine—Asthenia—Prednisone—systemic scleroderma	0.000332	0.000869	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—systemic scleroderma	0.000331	0.000866	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000319	0.000834	CcSEcCtD
Tranylcypromine—Diarrhoea—Prednisone—systemic scleroderma	0.000317	0.000829	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000316	0.000828	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—systemic scleroderma	0.000307	0.000804	CcSEcCtD
Tranylcypromine—Dizziness—Prednisone—systemic scleroderma	0.000306	0.000801	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—systemic scleroderma	0.000306	0.0008	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—systemic scleroderma	0.000306	0.0008	CcSEcCtD
Tranylcypromine—Vomiting—Prednisone—systemic scleroderma	0.000294	0.00077	CcSEcCtD
Tranylcypromine—Rash—Prednisone—systemic scleroderma	0.000292	0.000764	CcSEcCtD
Tranylcypromine—Dermatitis—Prednisone—systemic scleroderma	0.000291	0.000763	CcSEcCtD
Tranylcypromine—Headache—Prednisone—systemic scleroderma	0.00029	0.000759	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—systemic scleroderma	0.000277	0.000726	CcSEcCtD
Tranylcypromine—Nausea—Prednisone—systemic scleroderma	0.000275	0.00072	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—systemic scleroderma	0.000265	0.000693	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—systemic scleroderma	0.000256	0.00067	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—systemic scleroderma	0.000246	0.000644	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—systemic scleroderma	0.000244	0.000638	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—systemic scleroderma	0.000244	0.000638	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—systemic scleroderma	0.000242	0.000634	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—systemic scleroderma	0.00023	0.000601	CcSEcCtD
